LLS Services Impact on Blood Cancer Treatment
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 400 (estimated)
- Sponsor
- University of Miami · Other
This trial is looking for patients with blood cancer, such as leukemia or lymphoma, to understand how LLS services impact their care and quality of life. Participants will be asked to be followed for 6 months.
You may be able to join if
- I have been diagnosed with leukemia, lymphoma, myeloma, MDS, or MPN.
- I am currently receiving treatment for blood cancer.
- I started my treatment within the past 18 months.
- I plan to start treatment within the next month.
- I have received Bone Marrow Transplant or CAR-T cell therapy in the last 100 days.
- I am willing to be followed for 6 months.
- I speak English or Spanish.
- I am not currently participating in any LLS programs or services.
You may not be able to join if
- I have not been diagnosed with blood cancer.
- I do not meet the treatment requirements for blood cancer.
- I am currently participating in any LLS programs or services.
- I am not willing to be followed for 6 months.
- I do not speak English or Spanish.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
Loading trial locations…